Single-center, open, randomized controlled trial about Chinese fasting therapy in the reversal of type 2 diabetes with overweight or obesity

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047532

Enrollment

Unknown

Registered

2021-06-20

Start date

2022-03-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes with Overweight or Obesity

Interventions

Experimental group:Chinese fasting therapy

Control group:Conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Parient is aged 18 to 70 years; 2.According to the Chinese Guidelines of Type 2 Diabetes (2017 Edition), type 2 diabetes lasts within six years with overweight or obesity: 24kg/m^2 <= BMI <= 35kg/m^2; 3.Heart, liver, and kidney function is normal; 4.Signed the informed consent form. All the above four items conformed can enter the group.

Exclusion criteria

Exclusion criteria: 1.Patient has received insulin intensive therapy; 2.Pregnancy, lactation, or menstrual women; 3.Malignant tumor and hematonosis; 4.Patients with active tuberculosis; 5.Patients with ulcers with severe gastric bleeding; 6.Recently glylated hemoglobin >= 12%; 7.Other circumstances that investigators judging not suitable for inclusion.

Design outcomes

Primary

Measure	Time frame
remission rate of blood sugar;	—

Secondary

Measure	Time frame
weight loss range;	—

Countries

China

Contacts

Public ContactQin Jian

The Seventh Affiliated Hospital of Sun Yat-Sen University

hymybox@yeah.net+86 18902233983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026